Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise.

When Sam Taylor was 11, he thought he only had chronic headaches. It turned out to be a low-grade optic glioma, a type of ...

Scientists found that nearly every cancer harbors its own distinct community of microbes – tiny passengers that can influence how tumors start, spread, and respond to treatment, paving the way for a ...

In April 2022, Wendy Sanchez and her husband, Jonathan Barba, nearly died in a head-on collision in California's San Gabriel Mountains. More than two years later, the young woman was diagnosed with ...

Harlem rapper Sherard Dixon, better known as Posta Boy, passed away at 44 on Sunday, October 26. Bronx musician Mickey Factz ...

Introduction Precision oncology aims to provide individualised treatment recommendations based on patient-specific characteristics. In this rapidly evolving field with increasing numbers of biomarkers ...

Understanding the chemotherapy drugs you’re getting can help you feel more informed and prepared. Knowing the group that the chemo belongs to—and its exact name—can give you helpful context for why ...

Background: Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neurologic condition causing progressive muscle weakness that can occur as a paraneoplastic disorder, most commonly in patients ...

Henan International Joint Laboratory of Smart Molecules and Identification and Diagnostic Functions, School of Chemistry and Chemical Engineering, School of Physics, Henan Normal University, Xinxiang ...

Kerry Breen is a news editor at CBSNews.com. A graduate of New York University's Arthur L. Carter School of Journalism, she previously worked at NBC News' TODAY Digital. She covers current events, ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — The German biotech Tubulis, which is designing a series of ...

T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...